Cargando…
The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey
BACKGROUND: Withholding live-attenuated vaccines in patients using interleukin (IL)-1 or IL-6 blocking agents is recommended by guidelines for both pediatric and adult rheumatic diseases, since there is a risk of infection in an immune suppressed host. However, this has never been studied. This retr...
Autores principales: | Jeyaratnam, Jerold, ter Haar, Nienke M., Lachmann, Helen J., Kasapcopur, Ozgur, Ombrello, Amanda K., Rigante, Donato, Dedeoglu, Fatma, Baris, Ezgi H., Vastert, Sebastiaan J., Wulffraat, Nico M., Frenkel, Joost |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863478/ https://www.ncbi.nlm.nih.gov/pubmed/29562920 http://dx.doi.org/10.1186/s12969-018-0235-z |
Ejemplares similares
-
Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014) -
IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012) -
Management of Mevalonate Kinase Deficiency: A Pediatric Perspective
por: Jeyaratnam, Jerold, et al.
Publicado: (2020) -
Evidence based recommendations for diagnosis and management of mevalonate kinase defiency (MKD)
por: Haar, Nienke Ter, et al.
Publicado: (2014) -
IL-18 production upon s100 stimulation is reduced in active sJIA patients compared to sJIA patients in remission and healthy controls
por: Haar, Nienke Ter, et al.
Publicado: (2014)